Kayla Williams

Kayla Williams is an experienced professional in the field of medical writing, currently serving as the Director and Head of Oncology Medical Writing at Takeda since September 2016. With a progressive career that began at Aronex Pharmaceuticals in 1999, Kayla has held various roles leading medical writing teams and managing significant drug approvals, including ADCETRIS. Prior to Takeda, experience includes positions as Associate Director and Senior Manager of Medical Writing at Takeda Pharmaceuticals International Co. and Millennium Pharmaceuticals Inc., respectively. Kayla's early career includes roles at Synta Pharmaceuticals, as a Freelance Medical Writer, and as a Medical Technologist II at the University of Rochester. Educational qualifications include an MFA in Creative Writing and Poetry and an MA in English from McNeese State University, along with a BS in Biotechnology from the Rochester Institute of Technology.